Author:
Enns Benjamin,Krebs Emanuel,Whitehurst David G.T.,Jutras-Aswad Didier,Le Foll Bernard,Socias M. Eugenia,Nosyk Bohdan
Funder
Fonds de Recherche du Québec - Santé
Michael Smith Health Research BC
University of Toronto
National Institutes of Health
Canadian Institutes of Health Research
Centre for Addiction and Mental Health Foundation
Subject
Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology
Reference83 articles.
1. Adams, E., Sharifi, N., Lappalainen, L., 2017. Guideline for the Clinical Management of Opioid Use Disorder, vols 18-19. British Columbia Centre on Substance Use, p. 4.
2. Health-related quality of life in HIV-infected and at-risk women: the impact of illicit drug use and hepatitis C on a community preference weighted measure;Aden;Med. Decis. Mak.,2014
3. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada;Ali;Int. J. Drug Policy,2021
4. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment;Bell;Addiction,2009
5. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease;Briggs;Med. Decis. Mak.,2002
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献